Large-Section Histopathology Can Better Indicate the Immune Microenvironment and Predict the Prognosis of Pancreatic Ductal Adenocarcinoma Than Small-Section Histopathology
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor and is insensitive to radiotherapy and chemotherapy, as it is highly correlated with its complex tumor microenvironment (TME). A comprehensive description of PDAC’s immune microenvironment at the pathological level has not been repo...
Main Authors: | Guiling Ding, Meng Guo, Yelin Yang, Chen Sun, Shengyong Wu, Xingchen Liu, Jin Wang, Hui Jiang, Yanfang Liu, Jianming Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.694933/full |
Similar Items
-
A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection
by: Chaobin He, et al.
Published: (2020-09-01) -
A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics
by: Ningzi Tian, et al.
Published: (2022-07-01) -
The enigmatic helicase DHX9 as a candidate prognostic biomarker for resected pancreatic ductal adenocarcinoma
by: Le-gao Chen, et al.
Published: (2022-12-01) -
Pancreatic Ductal Adenocarcinoma at CT: A Combined Nomogram Model to Preoperatively Predict Cancer Stage and Survival Outcome
by: Chunyuan Cen, et al.
Published: (2021-05-01) -
Development and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort study
by: He C, et al.
Published: (2019-05-01)